| Issuer / Guarantor | Halozyme Therapeutics Inc |
|---|---|
| Size | USD 650mn |
| Type | Convertible |
| Leads | BoA, Morgan Stanley, JP Morgan, Wells Fargo, Goldman Sachs |
| Maturity | 15 Feb 2031 (5.3 years) |
| Coupon | 0% (0%) |
| Premium | 27.5% (25 - 30%) |
| Calls | NC3.25; PC @ 130% w table MW |
| Puts | t/o @ 100% |
| Div protection | Ratio adjustment (Full) |
| T/o protection | Make-whole table |
| CoCo | 130% to Aug 2030 (4.8 yrs) |
| Announced | 05 Nov 2025 |